MetLife Investment Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$76.1K Buy
+67,990
New +$76.1K ﹤0.01% 2653
2025
Q1
Sell
-16,641
Closed -$27.5K 2794
2024
Q4
$27.5K Sell
16,641
-26,011
-61% -$42.9K ﹤0.01% 2781
2024
Q3
$149K Sell
42,652
-17,337
-29% -$60.7K ﹤0.01% 2437
2024
Q2
$197K Buy
59,989
+21,660
+57% +$71K ﹤0.01% 2253
2024
Q1
$281K Sell
38,329
-5,675
-13% -$41.7K ﹤0.01% 1994
2023
Q4
$165K Hold
44,004
﹤0.01% 2345
2023
Q3
$93.3K Hold
44,004
﹤0.01% 2615
2023
Q2
$209K Hold
44,004
﹤0.01% 2248
2023
Q1
$251K Hold
44,004
﹤0.01% 2084
2022
Q4
$444K Hold
44,004
﹤0.01% 1713
2022
Q3
$986K Hold
44,004
0.01% 1198
2022
Q2
$1.09M Hold
44,004
0.01% 1168
2022
Q1
$1.71M Buy
44,004
+15,638
+55% +$606K 0.01% 1062
2021
Q4
$1.66M Hold
28,366
0.01% 932
2021
Q3
$1.68M Hold
28,366
0.02% 927
2021
Q2
$2.46M Hold
28,366
0.02% 779
2021
Q1
$2.34M Sell
28,366
-210
-0.7% -$17.3K 0.02% 809
2020
Q4
$2.6M Sell
28,576
-1,683
-6% -$153K 0.02% 704
2020
Q3
$1.21M Buy
30,259
+3,344
+12% +$134K 0.01% 941
2020
Q2
$923K Hold
26,915
0.01% 1070
2020
Q1
$598K Hold
26,915
0.01% 1121
2019
Q4
$527K Buy
26,915
+3,655
+16% +$71.5K 0.01% 1437
2019
Q3
$361K Sell
23,260
-4,623
-17% -$71.8K ﹤0.01% 1590
2019
Q2
$566K Hold
27,883
0.01% 1404
2019
Q1
$490K Hold
27,883
0.01% 1465
2018
Q4
$358K Buy
27,883
+4,805
+21% +$61.6K ﹤0.01% 1567
2018
Q3
$376K Hold
23,078
﹤0.01% 1716
2018
Q2
$262K Hold
23,078
﹤0.01% 1783
2018
Q1
$225K Buy
+23,078
New +$225K ﹤0.01% 1823